BioNTech (ADRs) will report on 05/08/2023 financial results for the quarter ended 03/31/2023.
On average, 10 analysts are forecasting earnings per share of EUR 0.265 compared to EUR 14.24 in the same quarter of the previous year.
On average, 9 analysts expect sales to drop by 83.35 percent to EUR 1.06 billion. In the same quarter of the previous year, sales of EUR 6.37 billion were on the books.
With a view to the current fiscal year, 15 analysts expect earnings per share of EUR 5.57 on average, while EUR 37.77 was generated in the previous year. In terms of sales, 15 analysts on average assume that a total of EUR 5.77 billion will be achieved in the current fiscal year, compared to EUR 17.31 billion in the previous year.
Editorial office finanzen.net
Leverage must be between 2 and 20
No data
More news about BioNTech (ADRs)
Image sources: Thomas Lohnes/Getty Images, Pavlo Gonchar/SOPA Images/LightRocket via Getty Images